The embodied artificial intelligence company StarEpoch has announced the completion of a new funding round worth 10 billion yuan. In just two months, this Tsinghua University-affiliated robotics firm has raised 25 billion yuan in a concentrated series of financings, serving as an example of capital continuing to cluster around leading projects in the embodied AI sector. According to incomplete statistics, StarEpoch has raised close to 50 billion yuan in total since the beginning of this year.
When the company secured 10 billion yuan in funding in March 2026, market sources indicated that StarEpoch's valuation had already surpassed 100 billion yuan. This latest round was led by Chengtong Fund, with participation from several major state-owned institutions including Jiangxi State-owned Capital Operation, Guoyuan Equity, Yufu Zhongxin Fund, and Hangzhou Capital. Follow-on investors included CICC Renault, Jiukun Venture Capital, Hony Capital, Juntai Capital, and Shenghe Capital. Existing shareholders such as Houxue Capital, Qingkong Tiancheng, and Qianshan Capital also increased their investments.
Founded in August 2023 and incubated by Tsinghua University's Institute for Interdisciplinary Information Sciences, StarEpoch was established by Chen Jianyu. Chen, an assistant professor and doctoral supervisor at the same institute, completed his undergraduate studies in Tsinghua's Department of Precision Instrument before earning his Ph.D. at the University of California, Berkeley. The company has chosen a technology path integrating both software and hardware. StarEpoch conducts full-stack in-house research and development centered on the "embodied brain" and "humanoid form," with capabilities covering brain algorithms, motion control, robot hardware, joint modules, and dexterous hands.
Within the embodied AI industry, the core debate over technical approaches has shifted beyond just the robot's physical appearance to how the robot understands tasks and executes actions. Major embodied large model architectures primarily fall into three categories: end-to-end Vision-Language-Action (VLA), a hierarchical brain-and-cerebellum structure, and world models. StarEpoch's ERA-42 follows the end-to-end VLA route, emphasizing integrated modeling from perception and understanding to motion control. Concurrently, the company is collaborating with Professor Chelsea Finn's team at Stanford University to advance research related to world models.
The successive funding rounds reflect the evolution of humanoid robots from simply being "able to move" to being "able to work." The logistics industry is a primary target for StarEpoch's product deployment. In April, the company disclosed collaborations with China Post and SF Group to deploy robots in over 10 logistics centers, with plans to commence batch deliveries of a thousand units in the second quarter of 2026.
Early-stage investment in embodied AI previously focused more on algorithm teams, academic backgrounds, and humanoid robot prototypes. However, starting in 2026, the narrative for leading companies' fundraising has shifted towards orders, deliveries, supply chains, and application scenarios. For local state-owned capital and industrial investors, embodied AI represents not just a frontier technology project but also a potential tool for upgrading industries such as manufacturing, logistics, pharmaceutical distribution, and e-commerce warehousing.
For StarEpoch, the new 10-billion-yuan infusion provides more than just financial resources. More crucially, with the entry of state capital, industrial investors, and existing shareholders, the company now faces pressure to demonstrate its mass delivery capabilities within a shorter timeframe. The year 2025 marked the starting point for the global scaling of the humanoid robot market. While growth has been encouraging, it must be acknowledged that production volumes remain relatively low. According to Omdia data, only three companies shipped over 1,000 units in 2025, all from China: Zhiyuan Robotics, Unitree Robotics, and Ubtech, with shipments of 5,168, 4,200, and 1,000 units respectively. IDC predicts that several leading Chinese manufacturers are expected to achieve ten-thousand-unit production capacity in 2026, further strengthening their scale supply capabilities and potentially solidifying their first-mover advantages.
It is reported that StarEpoch's first truly commercial order appeared in 2025, coming from an overseas research client interested in the company's XHAND1 five-finger dexterous hand. However, in terms of complete robot shipments, StarEpoch still lags behind the industry's top tier. Chen Jianyu believes that 2026 will be a pivotal year for embodied AI to transition from technological validation to commercial implementation. He expressed the hope that StarEpoch can achieve a shipment level in the thousands of units, with a longer-term goal of reaching ten thousand. Currently, the industry's biggest constraint is not the supply chain or delivery capability, but rather demand validation and product refinement. The window of opportunity in the embodied AI sector remains open, but the evaluation criteria are becoming more stringent. Model capabilities, hardware reliability, data loop efficiency, and supply chain costs will all ultimately be tested in real-world scenarios.